AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance

U.S. Markets open in 6 hrs 58 mins

Allergan plc (AGN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
216.14-0.10 (-0.05%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close216.24
Bid0.00 x
Ask0.00 x
Day's Range215.71 - 217.98
52 Week Range184.50 - 301.98
Avg. Volume5,263,304
Market Cap81.07B
PE Ratio (TTM)6.06
Earnings DateN/A
Dividend & Yield2.80 (1.30%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire32 minutes ago

    Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids

    DUBLIN and BUDAPEST, Hungary, Jan. 17, 2017 /PRNewswire/ -- Allergan Plc (AGN) and Gedeon Richter Plc. today announced positive results from Venus II, the second of two pivotal phase III clinical trials evaluating the efficacy and safety of ulipristal acetate in women with abnormal bleeding due to uterine fibroids.  A new drug application filing for ulipristal acetate is planned for the second half of 2017. "We are pleased with the favorable results of Venus II supporting the efficacy and safety profile of ulipristal acetate as shown in our Venus I trial," said David Nicholson, Chief Research and Development Officer, Allergan.

  • TheStreet.comyesterday

    Allergan, Schlumberger, IBM: Doug Kass' Views

    Doug Kass shares his thoughts on animal spirits, and discusses his astonishment at some rising optimism.

  • TheStreet.com3 days ago

    Jobless Claims and Trimming GLD: Best of Kass

    In highlights from this week's trading diary and posts, Kass tells us about how he's selling some Allergan shares and how he feels about the jobless claims.